Solution
Industries
Resources
About
Beacon Search

GENESEQ BIOSCIENCES

Company Snapshot

Founded: 2017
Entity Type: Private
Region: Australia
Headquarter: Victoria, Australia
Key Geographics: Asia-Pacific
Corporate Address: 205 177 Melbourne Victoria Australia Tel. +61-390-282-992 www.geneseq.com.au

Company Overview

Geneseq Biosciences is developing and commercializing liquid biopsy tests for cancer.

The company’s lead product, Melaseq, can detect microRNA of active melanoma in the blood. Melaseq measures 38 circulating microRNAs that are involved in regulating transformations that melanoma cells undergo as they become malignant. The microRNAs include three markers for angiogenesis and inflammation, 11 markers for immune processes and drug resistance, eight markers for tumor growth and 16 markers connected to invasion and metastasis.

Melaseq runs on NanoString’s technology platform.

In October 2018, Geneseq formed a partnership with Australian Clinical Labs to bring Melaseq to the market. Australian Clinical Labs is the largest pathology provider to public hospitals in Australia.

GENESEQ BIOSCIENCES In Reports

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

BCC Market Research Report for global liquid biopsy research tools, liquid biopsy biomarkers, technologies, services and diagnostics markets.

View All Reports

Company's Business Segments

  • Cancer Diagnostics : The company integrates genomics, machine learning, and AI to enhance the early and accurate diagnosis of cancer, predict treatment responses, and monitor patient outcomes.

Applications/End User Industries

  • Healthcare
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions